These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27151142)

  • 41. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
    Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles].
    Ishikawa H; Mitsui Y; Yoshitomi T; Mashimo K; Aoki S; Mukuno K; Shimizu K
    Nippon Ganka Gakkai Zasshi; 2001 Apr; 105(4):218-22. PubMed ID: 11329944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of recurrent dislocation of the temporomandibular joint with botulinum toxin: an alternative approach].
    Kotimäki J; Saarinen A
    Duodecim; 2011; 127(19):2088-91. PubMed ID: 22073541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A.
    Aquilina P; Vickers R; McKellar G
    Br J Oral Maxillofac Surg; 2004 Jun; 42(3):272-3. PubMed ID: 15121281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of injection of botulinum toxin on decreasing the symptoms and signs of masticatory muscles in patients with temporomandibular dysfunction.
    Ghavimi MA; Yazdani J; Afzalimehr A; Ghoreyshizadeh A; Dehnad SV
    J Dent Res Dent Clin Dent Prospects; 2019; 13(2):128-132. PubMed ID: 31592308
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B; Ozan B; Muğlali M; Celebi N
    Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Muscle pain in the head: overlap between temporomandibular disorders and tension-type headaches.
    Svensson P
    Curr Opin Neurol; 2007 Jun; 20(3):320-5. PubMed ID: 17495627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin: new treatment for temporomandibular disorders.
    Freund B; Schwartz M; Symington JM
    Br J Oral Maxillofac Surg; 2000 Oct; 38(5):466-71. PubMed ID: 11010775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mechanism of therapy effects by botulinum neurotoxin].
    Alajbegović A; Alajbegović S; Resić H
    Med Arh; 2008; 62(1):53-5. PubMed ID: 18543757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.
    Simpson LL; Maksymowych AB; Kouguchi H; Dubois G; Bora RS; Joshi S
    Protein J; 2005 Apr; 24(3):155-65. PubMed ID: 16096721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin type B (Myobloc): pharmacology and biochemistry.
    Callaway JE
    Clin Dermatol; 2004; 22(1):23-8. PubMed ID: 15158541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new botulinum toxin potentially bioequivalent to onabotulinumtoxinA: are there any differences at all?
    Yang GH; Jung HH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):165-70. PubMed ID: 23301820
    [No Abstract]   [Full Text] [Related]  

  • 55. Current gaps in basic science knowledge of botulinum neurotoxin biological actions.
    Rossetto O; Pirazzini M; Montecucco C
    Toxicon; 2015 Dec; 107(Pt A):59-63. PubMed ID: 26163315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin type A reduces inflammatory hypernociception induced by arthritis in the temporomadibular joint of rats.
    Lora VR; Clemente-Napimoga JT; Abdalla HB; Macedo CG; Canales GT; Barbosa CM
    Toxicon; 2017 Apr; 129():52-57. PubMed ID: 28209481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clostridium botulinum type E toxins bind to Caco-2 cells by a different mechanism from that of type A toxins.
    Zhang K; Yamamoto Y; Suzuki T; Yokota K; Ma S; Ni Nengah Dwi Fatmawati ; Oguma K
    Acta Med Okayama; 2012; 66(3):253-61. PubMed ID: 22729106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect.
    Durand PD; Couto RA; Isakov R; Yoo DB; Azizzadeh B; Guyuron B; Zins JE
    Aesthet Surg J; 2016 Apr; 36(4):482-7. PubMed ID: 26780946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Advances in botulinum toxin applications].
    Zaleski P
    Pol Merkur Lekarski; 1999 Sep; 7(39):134-7. PubMed ID: 10598494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of different temporomandibular joint sounds, with emphasis on disc-displacement, in patients with temporomandibular disorders and controls.
    Elfving L; Helkimo M; Magnusson T
    Swed Dent J; 2002; 26(1):9-19. PubMed ID: 12090160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.